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Introductory remarks$The enzymology dilemma
The post-genomic era is characterized by a gold-rush mood,
because many previously separate disciplines, ranging from
biology and biochemistry to physics, mathematics and
computer sciences, have grown together and contribute to
the generation of enormous amounts of experimental and
theoretical data. These data are published in journals and
often collected in electronic data repositories. Such
resources provide, as a challenge for intelligent data
mining, many potential chances to create new knowledge
and to gain insights into complex biological systems. One
approach of, for example, systems biologists, is not only to
depict the cellular metabolic pathways such as those drawn
in the well-known Boehringer poster or the KEGG pathway
map but to enter in the third dimension with a higher level
of information such as the e-cell project (Tomita et al.,
1999; Takahashi et al., 2004). Apart to the basic scientiﬁc
understanding of metabolic networks the application of
these digitized maps can also be useful for the simulation
of the treatment of diseases such as diabetes which could
lead to the development of new “intelligent” drugs (Werner,
2002).
However, the way to this scientiﬁc goldmine is paved with
serious problems. Have you also been faced with the
difﬁculty for comparing your kinetic data obtained from
your experimental results with those published in the
literature? Have you been interested in the effect of
directed mutations within the catalytic domain or within
structure determining sections of the protein on structure–
function relationships regarding the catalytic properties? Or
did you just want to understand the experimental results in
the literature and to draw the conclusion in reference to
the materials and methods described? Or have you tried to
construct a computer model on the basis of published data?0.1016/j.pisc.2014.02.013
he Authors. Published by Elsevier GmbH. This is an
mons.org/licenses/by/3.0/).
part of a special issue entitled “Reporting
RENDA Recommendations and Beyond”. Copy-
titut.The following brief examples will demonstrate the stum-
bling blocks on the way to the goldmine.
Imagine you are investigating the functional properties of
the enzymes of your particular interest. Appropriate, that is to
say published and proven, methodologies are applied and your
assays produce apparently reasonable results. Imagine you are
working on the characterization of the key enzymes of a well-
known metabolic pathway, which could be glycolysis in baker's
yeast. Your primary interest could be to understand the
interdependences of the metabolic control of this pathway
and thus you intend to supply the simulation algorithms such
as JWS Online (Olivier and Snoep, 2004) with your kinetic
data. However, before doing the theoretical work you want to
refer to the primary literature to seek for support for your own
experimental results. For this purpose the most productive
way would be to query enzyme data bases such as BRENDA
(Schomburg et al., 2013) or SABIO-RK (Wittig et al., 2012) to
obtain the appropriate references along with the functional
enzyme data and to enter these data in a spread sheet. After
the compilation of all relevant data you will make the
surprising discovery that the functional data is fragmented in
such a way that for particular enzymes there are no published
data at all, or that they exist but span an excessively broad
range. For example, Km values from the literature (as stored,
for example, in BRENDA) may have been measured at pH
values from 3 to more than 10, and at temperatures from 0 to
more than 100 1C. This is clearly not the fault of curators of
these databases, but arises from the inadequacy of the data in
the literature, since the functional data were extracted from
publications in primary biochemistry journals.
Imagine another researcher who characterizes the ATP-
coupled transport of ions across biological membranes.
Usually these transporters are ion pumps that couple the
transport of, for example, protons across the plasma
membrane or intra-cellular membranes of compartments
such as lysosomes or vacuoles against chemo-osmotic gra-
dients to the hydrolysis of ATP. Among other issues regarding
the catalytic properties of this enzyme, in particular, the
thermodynamic coupling ratio is the relationship of theopen access article under the CC BY license
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transported in the focus of research (Rea and Sanders,
1987). This ratio is calculated as a function of ΔG and both
the transport of charges and equilibrium reaction of the
hydrolysis of ATP (see for example Kettner et al., 2003).
However, this calculation requires the value of the apparent
equilibrium constant of the ATP hydrolysis, KATP, which
depends on a number of parameters such as the pH and
the concentrations of Mg2+, K+ and Ca2+ (Alberty, 1968;
Rosing and Slater, 1972). When the calculations have been
done our imaginary researcher wants to know whether his
coupling ratios are consistent with those previously pub-
lished with other organisms. However, he fails, despite
ﬁnding coupling ratios in biochemical or biophysical papers,
either because the calculations are not available or because
they are insufﬁciently set out in the Materials and Methods
section of the papers. Thus, he can neither understand
the published values nor compare his results with the
published ones.
These two following examples demonstrate the dilemma
of protein functional data:
Even though there are few projects that collect and
organize functional and kinetic enzyme data such as the
BRENDA database for enzyme functions and properties,
SABIO-RK for biochemical reactions within metabolic path-
ways, KEGG, BioCyc (Caspi et al., 2010), and BioCarta for
the representation of metabolic pathways, the availability
of comparable functional enzyme data is limited or some-
times non-existent. But this comparability based on homo-
geneous experimental designs is required when using the
kinetic data, for example for the understanding of the
metabolic ﬂux control.
The common property of, in particular, the enzyme data
collections is that they are created retrospectively, extract-
ing functional data from the literature by hand, a very
expensive, time-consuming and often error-prone process
that is never trivial. The difﬁculties derive from the fact
that the data are widely distributed among the journals
from different ﬁelds. Actually, the results from experimen-
tal work need to be interpreted and standardized to create
unambiguous data sets for the comprehensive description of
the individual enzyme.
The implementation of different experimental designs
affects signiﬁcantly the estimation of kinetic parameters.
For example different wavelengths applied to record NADH
oxidation in coupled optical tests may lead to different
values of the product concentrations, and thus to different
kinetic parameters for the enzyme (see for example Kettner
and Hicks, 2005).
In conclusion, data generated in laboratories that use
different methods result in large ranges of method-speciﬁc
data. Additionally, if the experimental conditions are not
clearly and fully stated, the data can, in worst cases, lead
to misinterpretations of laboratory ﬁndings when data move
between researchers whose laboratories employ individual
methods. In practice, kinetics data are sometimes extra-
polated from published experimental conditions and results
to different assay conditions and lead to “new” data with
high uncertainties. In particular, in silico analysis and
representations of metabolic systems are certainly impos-
sible under these circumstances (Stelling et al., 2002).
Nicolas Le Novère expressed the consequences moredrastically: “There is no point to exchanging quantitative
data or models if nobody understands the meaning of the
data and the content of the models beside their initial
generators.” (Le Novère et al., 2007). We have nothing
to add.
The “computational” community of metabolic network
researchers is not the only one that suffers from these
problems, and there are many other scientiﬁc reasons for
the requirement of enzyme data, such as for understanding
the contribution of complex biological pathways to human
pathophysiology and disease, for biotechnology applica-
tions, the representations of structure–function relation-
ships, the generation of a comprehensive enzyme compen-
dium, which in turn supports the interpretation of the
genome information by using a systematic and standardized
collection of functional enzyme data.
Therefore, successful research in the “omics” disciplines
requires functional protein data to be comprehensively
available, comparable, valid and reliable, ideally collected
under physiological standardized conditions.
How to improve this unsatisfactory situation?
It may seem too idealistic to try to create enzymology data
sets of the high quality needed. It may be tempting to take
enzyme data that are not truly comparable and to use them
for modeling and simulation anyway. If they are affected by
the lack of the availability of tools for data analysis
(because these data were obtained too long ago) so that
the kinetic parameters calculated do not ﬁt the experi-
mental data properly, or if experiments were carried out
under non-physiological conditions, they could be corrected
by recalculating the reaction mechanisms by using thermo-
dynamics criteria. The applicability of this approach was
demonstrated long ago, by Frieden and Alberty (1955), but
it faded into obscurity. Recently Beard et al. (2008) took up
this suggestion and reanalysed the kinetics of citrate
synthase (EC 2.3.3.1) in an exemplary manner, using data
from various sources. However, even though this approach
can be successful it is very time-consuming to collect all
relevant data from published sources and it is doubtful
whether the community will really proﬁt from such work by
using the rejuvenated data for further investigations.
Additionally, correction of calculated and published data
can be considered a retrospective method.
What about avoiding these correction requirements and
generating prospective comparable data by adopting appro-
priate recommendations or standards? However, what
does standardization mean, what kinds of standards are
available?
Uniform standard of practice
The basic idea of standardized assays is to unify the
experimental conditions when carrying out the experimen-
tal characterization of an identiﬁed enzyme. This can be
equated with the use of a single, uniform and agreed
methodology and would lead to a set of protocols or
experimental recipes that might be applicable for the study
of enzymes in comparable cellular environments. In mole-
cular biology protocols are not unusual, and are applied, for
3Quo Vadis, enzymology data?example, in procedures for heterologous expression of
proteins in yeast using vectors made in Escherichia coli, etc.
The hope is to signiﬁcantly reduce the method-dependent
between-laboratory variability of reported enzyme data
when applying uniform methodologies for enzyme charac-
terizations. In the ﬁeld of applied enzymology clinical
chemists were also concerned with the difﬁculty to inter-
pret enzyme-activity measurements in human serum due to
the numerous analytical procedures for enzyme assays
performed. This not only leads to uncertainties of the
physicians to diagnose the patients with a clear vision of a
disease and to decide for the correct therapy, but also
complicates the transfer of clinical laboratory results from
the literature to the daily medicinal treatment of the
patients. Therefore, in the 1970s the Enzyme Commission
of the Netherlands Society for Clinical Chemistry introduced
recommended methods for the determination of the activity
of a series of enzymes and subjected these uniform methods
a test under the supervision of the Netherlands National
External Quality Control Program. The trial showed a
decreased between-laboratory variation for the determina-
tion of aspartate aminotransferase and alanine aminotrans-
ferase from about 50% to about 15% for a group of 40
participating laboratories (Jansen et al., 1977). This proof
of increased consistency of laboratory experimental results
prompted the International Federation of Clinical Chemistry
and Laboratory Medicine (IFCC) to continue working on
guideline deﬁnitions on standard operation procedures for
a number of certain enzymes. The result is, for instance,
that after about 80% of laboratories in the United Kingdom
National External Quality Assessment Schemes (UK NEQAS)
had adopted the method for the measurement of creatine
kinase activity according to the IFCC guidelines the inter-
laboratory agreement dropped to a coefﬁcient of variation
of less than 10% (Moss, 1997).
In the basic research of pathway investigation, the ﬁrst
approaches to the application of uniform methods were
demonstrated for the experimental analysis of the enzymes
involved in glycolysis in baker's yeast. The strategy was ﬁrst
to evaluate the intra-cellular conditions for cells in a
determined environment and second to study the kinetics
of the enzymes involved under these “physiological” condi-
tions in comparison with commercially available enzymes
(van Eunen et al., 2010; see also van Eunen and Bakker,
2014). The successful demonstration of a proof-of-principle
suggests the application of this protocol to assay all other
enzymes in the yeast cytosol. In addition, the strategy
demonstrated here could serve as a template for the
standardization of experimental conditions in other com-
partments and organisms. There are some additional suc-
cess stories worthy of mention: within both the yeast
systems biology network (Mustacchi et al., 2006) and the
competence network of the systems biology of liver cells
(HepatoSys) (Klingmüller et al., 2006) ﬁrst approaches
towards the generation of comparable and reproducible
quantitative data under standardized experimental condi-
tions have been presented.
However, the disadvantages of uniform standards of
practice should not be concealed. Both analytical methods
and laboratory techniques are subject of permanent devel-
opments and improvements. Methods and techniques, once
recommended to and agreed by the community, willrespond slowly the technological advances. Recommended
methods also can become corrupted, either inadvertently,
by misinterpretation of the standards, or deliberately, to
accommodate the limitations imposed by automated instru-
mentation. Consequently, acceptance of these recom-
mended methods will decrease, and the procedures of
experiments will not comply with a uniform practice leading
to incomparable enzymology data. Last but not least, it is
questionable whether standard protocols can be applied to
enzymes of unknown function, identity or even cellular
localization. Finally, the results of many discussions raise
serious doubts about whether the scientiﬁc community
would be willing to adopt a particular recommendation
when the consequent lack of a clear advantage of one
method over another appears to provide no incentive
for users.Using reference enzymes as standards
Despite the widespread application of the IFCC guidelines it
has become obvious that this approach was reaching its
limits of improvement due to the disadvantages shown
above. In particular, for the IFCC guidelines it turned out
that transfer of some procedures was impractical for
routine test practices, such as temperature, the need for
sample blanks, long reaction times and limited linearity
(Panteghini et al., 2001). This observation drove the devel-
opment of additional components to the standardization of
methods, speciﬁcally the introduction of validated cali-
brated enzymes to act as reference systems and to replace
the use of theoretical and computational factors, which, in
turn, were usually dependent on the analytical system. The
use of these standards to normalize the individual labora-
tory results was rather successful in reducing inter-
laboratory variations from 50% without standard to 10%
with standard (Jansen and Jansen, 1983). In brief, the IFCC
Working Group on Calibrator in Clinical Enzymology has
worked out guidelines for the validation of enzyme calibra-
tors, created a network of reference laboratories where the
calibrations are carried out, and set up a global reference
system for the measurement of catalytic concentrations
(Ferrard et al., 1998). It is anticipated that the combination
of validated reference enzymes with the application of
standardized procedures will result in an increase of
reliability of enzyme data and in an improvement in both
inter-method and inter-laboratory agreement, leading to
valid diagnosis of diseases and therapy assessment.
However, the main disadvantage of the use of calibrated
enzymes as reference system is that there is only a relatively
small number of standards of speciﬁc enzymes available,
namely alkaline phosphatase, alanine aminotransferase,
α-amylase, aspartate aminotransferase, creatine kinase, γ-
glutamyltransferase, and lactate dehydrogenase. Furthermore,
these standards are usually restricted to routine tests in human
health care where the relevant enzymes that need to be
assayed are known. In contrast, basic enzymology research
takes place on a map of metabolic networks with many gaps
standing for unknown, unidentiﬁed or scientiﬁcally uncertain
catalytic entities.
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The development of an applicable framework of rules for
uniform experimental procedures implies a number of
advantages and disadvantages, as described above. After
such rules are available for applied enzymology, at least one
alternative to procedural standards could be to deﬁne
reporting standards, because both the implementation and
acceptance of such guidelines or recommendations can be
realised more rapidly. They could help to increase the value
of experimental data by clear and full statements of the
assay conditions used and by annotation of the results in
relation to the experimental environment.
However, reporting standards should not be considered a
straitjacket for the community, but as an important tool for
assisting researchers to draft their papers and to make the
results described reproducible. Indeed, the reality of scien-
tiﬁc publication shows that the quality of both the “Materi-
als and Methods” section and the “Results” section ranges
from very poor to reasonably useful. As the experimental
results should serve as a valid basis for the acceptance of
hypotheses, or for the creation of new hypotheses that need to
be accepted, again, both the materials and the methods
applied, and the data generated, must be reported accurately
in ways that do not allow misinterpretation. Even more,
enzymology data should be reported in standardized way to
link protein (structure) to enzyme function datasets and to
make them machine-readable for the creation of protein-
function databases. Apweiler et al. (2005, 2010) pointed out
the importance of standards when protein-function data are
reported in journals (see also Tipton et al., 2014).
A framework of criteria that determines a minimum of
data reported will help to ensure that data generated can
be located by researchers and computers alike, an impor-
tant pre-requisite for successful in silico analysis and
representation of metabolic systems. In recent years scien-
tists from diverse ﬁelds in computational and experimental
biology have been developing minimum information stan-
dards for improving the data quality in publications and
databases. The Minimum Information for Biological and
Biomedical Investigations (MIBBI) project has devoted great
efforts to coordinating the development of data standards
and to avoiding redundancy and incompatibility. MIBBI is
intended to be a one-stop-shop for minimum-information
checklists; it currently provides links to 39 registered
checklists in the portal section and assistance for the
creation of new, non-redundant guidelines in the foundry
section (Taylor et al., 2008). In the best case, authors can
access MIBBI to ﬁnd the most appropriate set of minimum
information guidelines when writing their papers. Examina-
tion of the publication guidelines of the major biochemistry
journals conﬁrms the emerging interest of their editors in
high-quality data reporting, as a growing number of these
journals have adopted community-based guidelines for data
standards. However, the checklist groups need to take into
account the constant changes in technology and methodol-
ogy, as well as modiﬁcations of laboratory standard prac-
tices that lead to the need for continual revision and
periodic updating of their lists.
The advantages of data reporting standards appear to be
obvious; potential problems with the standardization of enzyme
data in terms of good publication practice are so far unknown.Does the community like standards?
This is a typical question when rules and recommendations
are proposed, on account of suspicions that it may restrict
scientiﬁc freedom and potentially put researchers in a
straitjacket, as previously mentioned. Nobody likes rules
that must be obeyed but everybody claims to want high-
data quality in the literature. This appears to be an
unresolvable problem, however, reality is encouraging.
The answer on the question put in the section title is
simply “yes”. Surprisingly, the community demands for
standards according to a survey carried out by Edda Klipp
and colleagues in 2006 80% of the respondents consider
standards necessary whereas only 20% fear practical difﬁ-
culties caused by standards (Klipp et al., 2007). However,
there is also general consensus that standards that must be
applied under all circumstances should not be established:
they must be ﬂexible enough to permit alternatives or new
technological and methodological developments, standards
should be developed by the scientiﬁc community itself, in a
bottom-up approach instead of top-down, as this kind of
procedure has inherent impact on their perceived legiti-
macy, the acceptance of standards can only be successful if
they are supported by scientiﬁc journals, funding agencies
and community-based initiatives, as only these institutions
can enforce the use of standards.
In particular, the participants in this survey identiﬁed a
number of future tasks for standardization, amongst others
the standardization of experimental procedures and data
reporting to support modelers in network simulations and
database curators in data import and export. However,
setting standards has a number of implications that affect
not only on technical and scientiﬁc aspects but also touch
political issues. Holmes et al. (2010) describe in detail the
possible pitfalls, problems and solutions of standard setting
projects using the examples of the development of mini-
mum information checklists such as Minimum Information
About a Microarray Experiment (MIAME) and HUPO-PSI.
There are numerous other examples that indicate that
the scientiﬁc community does favor standards because
there is a general agreement that the current situation of
incomparable, to some extent invalid, and insufﬁciently
described enzymology data needs to be revised to provide
an incentive for successful data sharing between the
biological disciplines.Why and for whom this special issue?
A great number of authors from all many ﬁelds within
biochemistry, ranging from thermodynamic research to in
silico modeling of enzyme reactions and pathway interac-
tions, contributed to this book to address the issue of data
generation and reporting. The development of the nomen-
clature for enzymes and its adherent difﬁculties is consid-
ered as well as the IUBMB recommendations on Symbolism
and Terminology in Enzyme Kinetics (Nomenclature
Committee of IUB, 1982, 1983a, 1983b, 1992). The design
and implementation of both enzyme assays and high-
throughput assays is addressed in combination with the
analysis and interpretation of the experimental results. The
description of the impact of uniform and standardized data
5Quo Vadis, enzymology data?for database curation, the development of modeling algo-
rithms and for the interlaboratory data exchange may
underline all arguments that support the adoption of
standards by the scientiﬁc community for implementation
in its daily research routine. Examples of standards for basic
and applied enzyme research as well as suggestions for
quality assessment tools in the publication process complete
this collection of articles.
Both editors and authors hope that this collection will
help students and teachers to raise awareness of the
existence and the advantage of standards for conducting
research and reporting data. The adoption and acceptance
of standards is a mid-term project, and includes the need to
convince a wide range of people concerned that a potential
small — trivial, even — loss of academic freedom will be
replaced by substantial gain in the generation of scientiﬁc
knowledge.
We have tried to cover all of the appropriate topics, but
there will probably be some omissions that will need to be
dealt with in the future, either because we did not think of
them, or because we were unable to persuade suitable
authors to participate, and we shall appreciate it if readers
will draw our attention to these. Experience with commis-
sions that make recommendations tells us that nothing is
ever deﬁnitive and there are always revisions to be made.
To avoid giving the impression that we regard some
contributions as more important than others, we shall
mention the different articles in alphabetical order of their
authors. First, therefore, is the treatment of aspects of
particular importance for high-throughput screening,
described by Michael Acker and Douglas Auld. The require-
ments for more classical enzyme assays are described by
Hans Bisswanger. Athel Cornish-Bowden discusses the ana-
lysis of enzyme kinetic data, in particular the statistical
analysis of data, and in a separate article, describes the
IUBMB recommendations on enzyme kinetics—which are now
rather old and in some respects in urgent need of updating—
together with the IUBMB system for classifying enzyme-
catalysed reactions, which, in contrast, is kept continuously
up-to-date. Kevin Francis and Amnon Kohen discuss the
analysis of kinetic isotope effects. Robert Goldberg descri-
bes the application of standards in thermodynamics to
enzyme data. Peter Halling and Munishwar Gupta deal with
standards for application to industrial biocatalysis. Masaaki
Kotera, Susumu Goto and Minoru Kanehisa describe how
databases such as KEGG can be used predictively for
genome and metabolome studies. Octavio Monasterio deals
with the use of nuclear magnetic resonance for studying
enzyme catalysis. Ida Schomburg, Antje Chang and Dietmar
Schomburg discuss standardization in enzymology in the
context of the BRENDA database. Ulrike Wittig and 10
collaborators describe the problems that need to be con-
sidered and resolved in order to construct an enzyme
reaction database, speciﬁcally SABIO-RK. Finally—out of
alphabetical order because it deals with the whole purpose
of this collection—Keith Tipton and the members of the
Beilstein STRENDA Commission describe the work of this
Commission: why it exists and what has been achieved.
We, the guest editors of this collection, would like to
thank all authors who contributed to this collection with
both their overviews and thoughts about their area of
research interests and for making this special issue on topicsbeyond those discussed by the STRENDA Commission
possible.
Robert A. (Bob) Alberty, one of the giants of enzymology
of the past half century (Cornish-Bowden et al., 2010), had
a long life, but, sadly, not long enough to see the comple-
tion of this collection. He died on 18th January 2014 at the
age of 92. He was a loyal and enthusiastic supporter of the
work of STRENDA, and in particular he campaigned for a
rigorous treatment of biochemical thermodynamics, as will
be evident in particular in Robert Goldberg's article.
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